Concordia Pharmaceuticals Inc., a subsidiary of ADVANZ PHARMA, is a supplier of the branded version of Hydroxychloroquine in the US and the authorised generic version through our distribution partner.
We are currently out of stock of the branded version. This is due to the extremely challenging situation being faced by our contract manufacturing partner Sanofi to meet the rapid increase in demand for this medicine in the US market over the last few weeks.
Ensuring supply continuity is of paramount importance to ADVANZ PHARMA. Please be assured we are doing everything we can, working closely with our partner, to resume supply and anticipate stock delivery by end of May 2020.
However, the situation remains incredibly dynamic and things can change quickly, we will, therefore, continue to monitor the situation very closely.